Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


25.10.2021

1 Ann Intern Med
2 BMJ
7 Clin Infect Dis
1 J Immunol
3 J Infect Dis
3 Lancet
7 N Engl J Med
1 Nat Med
1 PLoS Med
6 PLoS One
2 Proc Natl Acad Sci U S A
9 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. NOVAZZI F, Taborelli S, Baj A, Focosi D, et al
    Asymptomatic SARS-CoV-2 Vaccine Breakthrough Infections in Health Care Workers Identified Through Routine Universal Surveillance Testing.
    Ann Intern Med. 2021 Oct 19. doi: 10.7326/M21-3486.
    PubMed        


    BMJ

  2. MAHASE E
    Covid-19: Valneva's vaccine produces stronger immune response than AstraZeneca's, company reports.
    BMJ. 2021;375:n2551.
    PubMed        

  3. ABBAS-HANIF A, Modi N, Smith SK, Majeed A, et al
    Covid-19 treatments and vaccines must be evaluated in pregnancy.
    BMJ. 2021;375:n2377.
    PubMed        


    Clin Infect Dis

  4. MARIN M, Fiebelkorn AP, Bi D, Coleman LA, et al
    Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine.
    Clin Infect Dis. 2021;73:e1546-e1553.
    PubMed         Abstract available

  5. HUANG W, Chiu NC, Chi H, Huang FY, et al
    Inoculation Age of Bacillus Calmette-Guerin Tokyo-172 Strain and Vaccine-related Adverse Reactions in Taiwan Birth Cohort of 2012-2017.
    Clin Infect Dis. 2021;73:e1554-e1559.
    PubMed         Abstract available

  6. MARSHALL HS, Maiden MCJ
    Impact of a Meningococcal Protein-based Serogroup B Vaccine on Serogroup W Invasive Disease in Children.
    Clin Infect Dis. 2021;73:e1669-e1672.
    PubMed        

  7. LADHANI SN, Campbell H, Andrews N, Parikh SR, et al
    First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England.
    Clin Infect Dis. 2021;73:e1661-e1668.
    PubMed         Abstract available

  8. LYKE KE, Singer A, Berry AA, Reyes S, et al
    Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection.
    Clin Infect Dis. 2020 Sep 12. pii: 5904973. doi: 10.1093/cid/ciaa1294.
    PubMed         Abstract available

  9. ISTURIZ R, Grant L, Gray S, Alexander-Parrish R, et al
    Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults.
    Clin Infect Dis. 2021;73:1216-1222.
    PubMed         Abstract available

  10. HURLEY D, Griffin C, Young M, Scott DA, et al
    Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
    Clin Infect Dis. 2021;73:e1489-e1497.
    PubMed         Abstract available


    J Immunol

  11. BANSAL S, Perincheri S, Fleming T, Poulson C, et al
    Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.
    J Immunol. 2021 Oct 15. pii: jimmunol.2100637. doi: 10.4049/jimmunol.2100637.
    PubMed         Abstract available


    J Infect Dis

  12. CHAKRABORTY D, Kanungo S, Nandy RK, Deb AK, et al
    Challenges for Programmatic Implementation of Oral Cholera Vaccine in India.
    J Infect Dis. 2021 Oct 20. pii: 6404482. doi: 10.1093.
    PubMed         Abstract available

  13. CALLEGARO A, Burny W, Herve C, Kim JH, et al
    Association between immunogenicity and reactogenicity: a post hoc analysis of two Phase 3 studies with the adjuvanted recombinant zoster vaccine.
    J Infect Dis. 2021 Oct 18. pii: 6400271. doi: 10.1093.
    PubMed         Abstract available

  14. WITHANAGE K, De Coster I, Cools N, Viviani S, et al
    Phase 1 randomized, placebo-controlled, dose-escalating study to evaluate OVX836, a nucleoprotein-based influenza vaccine: intramuscular results.
    J Infect Dis. 2021 Oct 15. pii: 6398205. doi: 10.1093.
    PubMed         Abstract available


    Lancet

  15. SAMARASEKERA U
    Cautious optimism for malaria vaccine roll-out.
    Lancet. 2021;398:1394.
    PubMed        

  16. SAAG MS
    Developing COVID-19 vaccine policy in increments.
    Lancet. 2021;398:1382-1383.
    PubMed        

  17. THE LANCET
    Malaria vaccine approval: a step change for global health.
    Lancet. 2021;398:1381.
    PubMed        


    N Engl J Med

  18. TAN CW, Chia WN, Young BE, Zhu F, et al
    Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors.
    N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMoa2108453.
    PubMed         Abstract available

  19. RUBIN EJ, Baden LR, Tofel R, Morrissey S, et al
    Audio Interview: Covid-19 and the Media.
    N Engl J Med. 2021;385:e59.
    PubMed        

  20. REIS BY, Barda N, Leshchinsky M, Kepten E, et al
    Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114290.
    PubMed        

  21. SHEIKH A, Robertson C, Taylor B
    BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2113864.
    PubMed        

  22. CHIN ET, Leidner D, Zhang Y, Long E, et al
    Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114089.
    PubMed        

  23. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Look at Covid-19 Vaccine Boosters.
    N Engl J Med. 2021;385:e72.
    PubMed        

  24. MAGNUS MC, Gjessing HK, Eide HN, Wilcox AJ, et al
    Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114466.
    PubMed        


    Nat Med

  25. POUWELS KB, Pritchard E, Matthews PC, Stoesser N, et al
    Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK.
    Nat Med. 2021 Oct 14. pii: 10.1038/s41591-021-01548.
    PubMed         Abstract available


    PLoS Med

  26. ISANAKA S, Garba S, Plikaytis B, McNeal MM, et al
    Correction: Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: A cluster randomized clinical trial.
    PLoS Med. 2021;18:e1003776.
    PubMed         Abstract available


    PLoS One

  27. ROUBY SR, Safwat NM, Hussein KH, Abdel-Ra'ouf AM, et al
    Lumpy skin disease outbreaks in Egypt during 2017-2018 among sheeppox vaccinated cattle: Epidemiological, pathological, and molecular findings.
    PLoS One. 2021;16:e0258755.
    PubMed         Abstract available

  28. WIN TTZ, Campbell A, Magalhaes RJS, Oo KN, et al
    What drives small-scale farmers to vaccinate their multiple livestock species animals against common infectious diseases in Myanmar?
    PLoS One. 2021;16:e0258765.
    PubMed         Abstract available

  29. MALAMBA SS, Muyinda H, Ogwang DM, Katamba A, et al
    Cango Lyec (Healing the Elephant): Chronic Hepatitis B Virus among post-conflict affected populations living in mid-Northern Uganda.
    PLoS One. 2021;16:e0251573.
    PubMed         Abstract available

  30. KURTZ SL, De Pascalis R, Meierovics AI, Elkins KL, et al
    Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity.
    PLoS One. 2021;16:e0249142.
    PubMed         Abstract available

  31. COHEN AA, Yang Z, Gnanapragasam PNP, Ou S, et al
    Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers.
    PLoS One. 2021;16:e0247963.
    PubMed         Abstract available

  32. ALISHAQ M, Nafady-Hego H, Jeremijenko A, Al Ajmi JA, et al
    Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.
    PLoS One. 2021;16:e0258820.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  33. LE NOUEN C, McCarty T, Yang L, Brown M, et al
    Rescue of codon-pair deoptimized respiratory syncytial virus by the emergence of genomes with very large internal deletions that complemented replication.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  34. PISHESHA N, Harmand TJ, Rothlauf PW, Praest P, et al
    A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Vaccine

  35. MAKI Y, Kashiwagi S, Kimizuka Y
    Laser vaccine adjuvants: Light-augmented immune responses.
    Vaccine. 2021 Oct 16. pii: S0264-410X(21)01233.
    PubMed         Abstract available

  36. REIDENBERG BE, Hirsch K, Costello CM, Russo M, et al
    Drive through COVID19 vaccination for developmentally disabled persons.
    Vaccine. 2021 Oct 6. pii: S0264-410X(21)01279.
    PubMed        

  37. AYAZ S, Dibben O, Chapman D
    Presence of defective viral genes in H1N1 live attenuated influenza vaccine strains is not associated with reduced human cell fitness or vaccine effectiveness.
    Vaccine. 2021 Oct 15. pii: S0264-410X(21)01320.
    PubMed         Abstract available

  38. MOTTELSON A, Vandeweerdt C, Atchapero M, Luong T, et al
    A self-administered virtual reality intervention increases COVID-19 vaccination intention.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01311.
    PubMed         Abstract available

  39. SILVER MC, Neumann PJ, Ma S, Kim DD, et al
    Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines.
    Vaccine. 2021 Oct 13. pii: S0264-410X(21)01285.
    PubMed         Abstract available

  40. MOGHNIEH R, Mekdashi R, El-Hassan S, Abdallah D, et al
    Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon.
    Vaccine. 2021 Oct 13. pii: S0264-410X(21)01314.
    PubMed         Abstract available

  41. LALWANI SK, Ramanan PV, Sapru A, Sundaram B, et al
    Safety and immunogenicity of a multidose vial formulation of 13-valent pneumococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants in India: A phase 4, randomized, open-label study.
    Vaccine. 2021 Oct 13. pii: S0264-410X(21)01208.
    PubMed         Abstract available

  42. TRAN VN, Nguyen HA, Le TTA, Truong TT, et al
    Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
    Vaccine. 2021;39:6485-6491.
    PubMed         Abstract available

  43. BUUS M, da Silva I, Nielsen S, Thysen SM, et al
    Coverage and factors associated with receiving campaign polio vaccines in an urban population in Guinea-Bissau.
    Vaccine. 2021 Oct 12. pii: S0264-410X(21)01150.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: